Stock Events

Stock Events

Entheon Biomedical 

$0.004100
2
-$0.01-59% Friday 19:46

Statistics

Day High
0.0041
Day Low
0.0041
52W High
0.104
52W Low
0.001
Volume
16
Avg. Volume
235
Mkt Cap
56,817.8
P/E Ratio
0.5
Dividend Yield
-
Dividend
-

Earnings

31AugExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-0.05
-0.03
-0.01
0.01
Expected EPS
N/A
Actual EPS
0.006

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-229,731.63Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.84B
Compass Pathways operates in the psychedelic medicine sector, focusing on psilocybin therapy for depression, similar to Entheon's focus on psychedelic therapies.
AtaiBeckley
ATAI
Mkt Cap2.74B
ATAI Life Sciences is a biotech company developing psychedelic and non-psychedelic compounds for mental health disorders, overlapping with Entheon's market.
GH Research
GHRS
Mkt Cap1.94B
GH Research focuses on developing 5-MeO-DMT therapies for depression, a direct competitor in the psychedelic treatment space.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, directly competing with Entheon's business model in mental health.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics explores psilocybin-based therapies, which is a direct competition to Entheon's psychedelic research and development.
Noveris Health Sciences
MYCOF
Mkt Cap64.4M
Mydecine Innovations Group focuses on developing and commercializing psychedelic medicines, competing in the same niche as Entheon.

About

Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Timothy Ko
Country
Canada
ISIN
CA29383X2023
WKN
000A404YT

Listings

F
DE
1XU.F
CN
CA
ENBI-X.CN
STU
DE
1XU.STU
MU
DE
1XU1.MU

0 Comments

Share your thoughts

FAQ

What is Entheon Biomedical stock price today?▼
The current price of ENTBF is $0.00 USD — it has decreased by -59% in the past 24 hours. Watch Entheon Biomedical stock price performance more closely on the chart.
What is Entheon Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Entheon Biomedical stocks are traded under the ticker ENTBF.
Is Entheon Biomedical stock price growing?▼
ENTBF stock has fallen by -89.21% compared to the previous week, the month change is a +2.5% rise, over the last year Entheon Biomedical has showed a -94.06% decrease.
What is Entheon Biomedical market cap?▼
Today Entheon Biomedical has the market capitalization of 56,817.8
What were Entheon Biomedical earnings last quarter?▼
ENTBF earnings for the last quarter are 0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Entheon Biomedical revenue for the last year?▼
Entheon Biomedical revenue for the last year amounts to 0 USD.
What is Entheon Biomedical net income for the last year?▼
ENTBF net income for the last year is -229,731.63 USD.
In which sector is Entheon Biomedical located?▼
Entheon Biomedical operates in the Health & Wellness sector.
When did Entheon Biomedical complete a stock split?▼
The last stock split for Entheon Biomedical was on March 01, 2024 with a ratio of 1:10.
Where is Entheon Biomedical headquartered?▼
Entheon Biomedical is headquartered in Vancouver, Canada.